Evaluation of the automated BD Phoenix CPO Detect test for detection and classification of carbapenemases in Gram negatives.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 29 07 2019
revised: 02 10 2019
accepted: 02 10 2019
pubmed: 23 11 2019
medline: 10 6 2020
entrez: 23 11 2019
Statut: ppublish

Résumé

We evaluated the performance of the automated BD Phoenix CPO Detect test (BD-CPO test) for detection and Ambler classification of carbapenemases in Enterobacteriaceae, P.aeruginosa and A.baumannii complex. A collection of 287 Gram-negative clinical isolates, with a reduced susceptibility to at least one carbapenem including 184 carbapenemase-producing organisms (CPO) and 103 non-CPO, was tested. The BD-CPO test showed an overall sensitivity of 89.7% and specificity of 83.5% for carbapenemase detection. 1/7 of class A, 82.9% of class B, and 89.8% of class D carbapenemases were correctly classified. Poor detection sensitivity of 68.9% and specificity of 62.1% in P.aeruginosa was observed. However, combination with ceftazidime/avibactam susceptibility, provided by this panel, increased the performances for P.aeruginosa. The integration of an automated carbapenemase detection and classification in routine susceptibility panels would save time and help for therapeutic management. Further developments are needed to improve the accuracy of the BD-CPO test.

Identifiants

pubmed: 31753520
pii: S0732-8893(19)30764-3
doi: 10.1016/j.diagmicrobio.2019.114911
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114911

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Imane Saad Albichr (I)

Department of Microbiology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Ahalieyah Anantharajah (A)

Department of Microbiology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Magali Dodémont (M)

Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB), Hôpital Erasme-Cliniques universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Marie Hallin (M)

Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB), Hôpital Erasme-Cliniques universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Alexia Verroken (A)

Department of Microbiology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Hector Rodriguez-Villalobos (H)

Department of Microbiology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: hector.rodriguez@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH